Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
McKinsey
Express Scripts
AstraZeneca
Moodys

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019726

See Plans and Pricing

« Back to Dashboard

NDA 019726 describes ZOLADEX, which is a drug marketed by Tersera Theraps Llc and is included in two NDAs. It is available from three suppliers. There are three patents protecting this drug. Additional details are available on the ZOLADEX profile page.

The generic ingredient in ZOLADEX is goserelin acetate. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the goserelin acetate profile page.
Summary for 019726
Tradename:ZOLADEX
Applicant:Tersera Theraps Llc
Ingredient:goserelin acetate
Patents:3
Formulation / Manufacturing:see details
Generic Entry Opportunity Date for 019726
Generic Entry Date for 019726*:
Constraining patent/regulatory exclusivity:
Dosage:
IMPLANT;IMPLANTATION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for NDA: 019726
Medical Subject Heading (MeSH) Categories for 019726
Suppliers and Packaging for NDA: 019726
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726 NDA AstraZeneca Pharmaceuticals LP 0310-0950 0310-0950-36 1 POUCH in 1 CARTON (0310-0950-36) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE
ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726 NDA A-S Medication Solutions 50090-2027 50090-2027-0 1 POUCH in 1 CARTON (50090-2027-0) > 1 IMPLANT in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:IMPLANT;IMPLANTATIONStrengthEQ 3.6MG BASE
Approval Date:Dec 29, 1989TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Apr 13, 2022Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Apr 9, 2022Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Feb 26, 2021Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 019726

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989   Start Trial   Start Trial
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Express Scripts
Dow
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.